TSPAN8 and familial pancreatic carcinoma: In another study, TSPAN8, alongside CD44v6, an α6β4 integrin, and CD133, were found to be upregulated in pancreatic cancer-initiating cells (Pa-CIC), where they conferred in vivo growth and metastatic advantages [148].